Case number 2020-2068
Sanofi-Aventis Deutschland v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 22, 2022 | 30 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [832663] [20-2066, 20-2068, 20-2069] [MVH] [Entered: 02/22/2022 02:13 PM] (1) |
| Dec 29, 2021 | 28 | OPINION filed for the court by Dyk, Circuit Judge; Clevenger, Circuit Judge and Taranto, Circuit Judge. Nonprecedential Per Curiam Opinion. Service as of this date by the Clerk of Court. [821668] [20-2066, 20-2068, 20-2069] [MVH] [Entered: 12/29/2021 10:05 AM] (8) |
| Dec 29, 2021 | 29 | JUDGMENT. AFFIRMED IN PART, DISMISSED IN PART. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [821669] [20-2066, 20-2068, 20-2069] [MVH] [Entered: 12/29/2021 10:06 AM] (2) |
| Jun 23, 2021 | 27 | ORDER filed. Within 14 days from the date of this order, the parties that raised an Appointments Clause challenge shall file a brief, not to exceed 10 pages double-spaced, explaining how they believe their cases should proceed in light of Arthrex. Responses from the other parties, including the United States Patent and Trademark Office, subject to the same length restrictions, are due within 14 days thereafter. All deadlines and proceedings are stayed. Service as of this date by the Clerk of Court. [782107] [20-1874, 20-1886, 20-1890, 20-1927, 20-1930, 20-1946, 20-1947, 20-1948, 20-1961, 20-1992, 20-1994, 20-2001, 20-2059, 20-2066, 20-2068, 20-2069, 20-2071] [MJL] [Entered: 06/23/2021 05:04 PM] (2) |
| Jan 27, 2021 | 26 | ORDER granting [748890-2] [748891-2] [748893-2] the motions. The revised official captions are reflected above. Appeal No. 2020-2144 is withdrawn. Each side shall bear its own costs with respect to Appeal No. 2020-2144. ISSUED AS A MANDATE (as to Appeal No. 2020-2144 only): January 27, 2021. Service as of this date by the Clerk of Court. [751964] [20-1871, 20-2029, 20-2032, 20-2033, 20-2034, 20-2159, 20-2066, 20-2068, 20-2069, 20-2071, 20-2144] [LMS] [Entered: 01/27/2021 08:28 AM] (0) |
| Sep 25, 2020 | 24 | ORDER granting motion to consolidate appeals [17] filed by Appellant Sanofi-Aventis Deutschland GmbH in 20-2068; denying [17] motion to waive requirements of brief or appendix filed by Sanofi-Aventis Deutschland GmbH in 20-2068; denying [17] motion to set briefing schedule filed by Sanofi-Aventis Deutschland GmbH in 20-2068; consolidating appeals (20-2066, 20-2068, and 20-2069.). The stays of the briefing schedules are lifted. The opening briefs for each group of appeals are due within 60 days from the filing date of the last-filed Certified List within each group. Service as of this date by the Clerk of Court. [724584] [20-2066, 20-2068, 20-2069] [LMN] [Entered: 09/25/2020 03:53 PM] (0) |
| Sep 25, 2020 | 25 | Note to File: The following cases are consolidated: 20-2066 Lead with 20-2068 and 20-2069 Member Cases. The parties must file all documents in the lead appeal only. [724585] [20-2066, 20-2068, 20-2069] [LMN] [Entered: 09/25/2020 03:56 PM] (0) |
| Sep 9, 2020 | 23 | Certified list received. Service: 09/08/2020 by email. [720299] [20-2068, 20-2069] [EKD] [Entered: 09/09/2020 09:27 AM] (0) |
| Aug 25, 2020 | 22 | ORDER staying the briefing schedules pending disposition of the motions. Service as of this date by the Clerk of Court. [717299] [20-1871, 20-2033, 20-2068, 20-2159] [LMS] [Entered: 08/25/2020 11:05 AM] (0) |
| Aug 12, 2020 | 21 | REPLY of Appellant Sanofi-Aventis Deutschland GmbH to response [20]. Service: 08/12/2020 by email. [714350] [20-2068] [Adam Banks] [Entered: 08/12/2020 09:18 AM] (0) |
| Aug 7, 2020 | 19 | REMINDER: Attorney Scott Flanz is reminded that the information on the Entry of Appearance (EOA) and the information in the user account must match. Please promptly update the EOA or the account information on www.pacer.gov. [713244] [EKD] [Entered: 08/07/2020 09:34 AM] (0) |
| Aug 7, 2020 | 20 | RESPONSE of Appellee Mylan Pharmaceuticals Inc. to the motion to consolidate appeals [17] filed by Appellant Sanofi-Aventis Deutschland GmbH, motion to waive requirements of brief or appendix [17] filed by Appellant Sanofi-Aventis Deutschland GmbH, motion to set briefing schedule [17] filed by Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/07/2020 by email. [713510] [20-2068] [Douglas Carsten] [Entered: 08/07/2020 06:48 PM] (0) |
| Aug 6, 2020 | 18 | Entry of appearance for Lauren A. Degnan; John S. Goetz; and Scott Flanz as counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/06/2020 by email. [713142] [20-2068] [Lauren Degnan] [Entered: 08/06/2020 04:25 PM] (0) |
| Aug 5, 2020 | 17 | MOTION of Appellant Sanofi-Aventis Deutschland GmbH to consolidate appeals (2020-2066, 2020-2068, 2020-2069), to waive the requirements regarding the brief (enlarge word limitation, Fed. Cir. R. 32(a)), to set briefing schedule [Consent: opposed]. Service: 08/05/2020 by email. [712845] [20-2068] [Adam Banks] [Entered: 08/05/2020 05:14 PM] (0) |
| Aug 5, 2020 | 11 | Entry of appearance for Charles B. Klein; Jovial Wong; Dan H. Hoang as counsel for Appellee Pfizer Inc.. Service: 08/05/2020 by email. [712760] [20-2068] [Charles Klein] [Entered: 08/05/2020 03:02 PM] (2) |
| Aug 5, 2020 | 12 | Certificate of Interest for Appellee Pfizer Inc.. Service: 08/05/2020 by email. [712761] [20-2068] [Charles Klein] [Entered: 08/05/2020 03:04 PM] (3) |
| Aug 5, 2020 | 13 | Docketing Statement for the Appellee Pfizer Inc.. Service: 08/05/2020 by email. [712763] [20-2068] [Charles Klein] [Entered: 08/05/2020 03:06 PM] (3) |
| Aug 5, 2020 | 14 | Entry of appearance for Adam B. Banks; Elizabeth Stotland Weiswasser; Anish R. Desai; W. Sutton Ansley; Sarah M. Sternlieb as counsel for Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/05/2020 by email. [712839] [20-2068] [Adam Banks] [Entered: 08/05/2020 05:04 PM] (2) |
| Aug 5, 2020 | 15 | Certificate of Interest for Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/05/2020 by email. [712841] [20-2068] [Adam Banks] [Entered: 08/05/2020 05:06 PM] (3) |
| Aug 5, 2020 | 16 | Docketing Statement for the Appellant Sanofi-Aventis Deutschland GmbH. Service: 08/05/2020 by email. [712843] [20-2068] [Adam Banks] [Entered: 08/05/2020 05:07 PM] (3) |
| Aug 4, 2020 | 5 | Entry of appearance for Douglas H. Carsten; Richard Torczon; Elham F. Steiner; Adam Burrowbridge; Wesley E. Derryberry; Tasha M. Thomas as counsel for. Service: 08/04/2020 by email. [712254] [20-2068] This document is non-compliant. See Doc No. [8] [Richard Torczon] [Entered: 08/04/2020 10:12 AM] (2) |
| Aug 4, 2020 | 6 | Certificate of Interest for Appellee Mylan Pharmaceuticals Inc.. Service: 08/04/2020 by email. [712258] [20-2068] [Richard Torczon] [Entered: 08/04/2020 10:14 AM] (3) |
| Aug 4, 2020 | 7 | Docketing Statement for the Appellee Mylan Pharmaceuticals Inc.. Service: 08/04/2020 by email. [712260] [20-2068] [Richard Torczon] [Entered: 08/04/2020 10:20 AM] (3) |
| Aug 4, 2020 | 8 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Mylan Pharmaceuticals Inc., Entry of Appearance [5], is not in compliance with the rules of this court (see attached). Compliant document is due on 08/11/2020. Service as of this date by the Clerk of Court. [712310] [EKD] [Entered: 08/04/2020 11:16 AM] (1) |
| Aug 4, 2020 | 9 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [6], Doc No. [7], ERROR: The case number on the documents is incomplete. Fed. R. App. P. 32(a)(2)(A); Fed. R. App. P. 32(c)(2)(A). CORRECTION: For all future filings, please include lead case number, 20-2068, and consolidated member case number, 20-2069. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [712312] [EKD] [Entered: 08/04/2020 11:23 AM] (0) |
| Aug 4, 2020 | 10 | Corrected Entry of appearance for Douglas H. Carsten; Richard Torczon; Elham F. Steiner; Adam Burrowbridge; Wesley E. Derryberry; Tasha M. Thomas as counsel for Appellee Mylan Pharmaceuticals Inc.. Service: 08/04/2020 by email. [712448] [20-2068] [Richard Torczon] [Entered: 08/04/2020 03:01 PM] (2) |
| Jul 31, 2020 | 4 | Note to File: The following cases shall be considered companion cases and assigned to the same merits panel: 20-1871, 20-2033, and 20-2068. [711631] [20-1871, 20-2033, 20-2068] [EKD] [Entered: 07/31/2020 02:19 PM] (0) |
| Jul 30, 2020 | 2 | ORDER consolidating appeals 20-2068 and 20-2069. The Certified Lists are due no later than September 8, 2020. Service as of this date by the Clerk of Court. [711401] [20-2068, 20-2069] [EKD] [Entered: 07/30/2020 04:35 PM] (2) |
| Jul 30, 2020 | 3 | Note to File: The following cases are consolidated: 20-2068 Lead with 20-2069 Consolidated Member Case. The parties must file all documents in the lead appeal only. [711402] [20-2068, 20-2069] [EKD] [Entered: 07/30/2020 04:37 PM] (0) |
| Jul 27, 2020 | 1 | Appeal docketed. Received: 07/23/2020. [710315] Entry of Appearance is due on 08/10/2020. Certificate of Interest is due on 08/10/2020. Docketing Statement is due on 08/10/2020. Certified List is due on 09/08/2020. [EKD] [Entered: 07/27/2020 03:21 PM] (143) |
